Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCT3N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,458
Award facts
- Contract value 100% obligated
- $2,458.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,458.10 on December 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 8, 2025. Zepbound is a GLP-1 receptor agonist used for weight management in eligible patients and represents part of the broader pharmaceutical product portfolio that AmerisourceBergen supplies to federal healthcare systems.
This delivery order is executed under AmerisourceBergen's substantial $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs and affiliated federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract performance demonstrates significant capability in fulfilling diverse medical supply requirements through open competition, positioning the company as a critical vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FCT3N?
SPE2DR26FCT3N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FCT3N worth?
The government has obligated $2,458 on SPE2DR26FCT3N.
Is contract SPE2DR26FCT3N an order under another contract?
Yes. SPE2DR26FCT3N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT3N competed?
The extent of competition for SPE2DR26FCT3N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award